Quick Answer
Benitec Biopharma Inc. reported Common Stock Shares Outstanding of 26.25 million shares for the year ending 2025.
- Benitec Biopharma Inc. showed an increase of +2.8% in Common Stock Shares Outstanding from 2025 to 2025.
- This data is from Benitec Biopharma Inc.'s annual report (Form 10-K), filed with the SEC on September 22, 2025.
- XBRL data for this metric is available from 2019 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2020: 1.11 million shares | Q4 2020: 4.54 million shares | Q1 2021: 4.82 million shares | Q3 2021: 8.17 million shares | Q4 2021: 8.17 million shares | Q1 2022: 8.17 million shares | Q3 2022: 25.81 million shares | Q4 2022: 27.98 million shares | Q1 2023: 27.98 million shares | Q3 2023: 2.55 million shares | Q4 2023: 2.59 million shares | Q1 2024: 2.72 million shares | Q3 2024: 17.89 million shares | Q2 2025: 26.25 million shares | Q3 2025: 26.25 million shares | Q4 2025: 34.25 million shares.
- Over the full 9 years of available data (2019 to 2025), Benitec Biopharma Inc.'s Common Stock Shares Outstanding has grown by 2,963.9%.
- Historical annual values: Fiscal year 2025: 26.25 million shares | Fiscal year 2025: 25.55 million shares | Fiscal year 2024: 23.45 million shares | Fiscal year 2024: 10.09 million shares | Fiscal year 2023: 1.67 million shares | Fiscal year 2022: 480,688 shares | Fiscal year 2021: 8.17 million shares | Fiscal year 2020: 1.11 million shares | Fiscal year 2019: 856,765 shares.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: